SCHEMBL4291472

SCHEMBL4291472

CCOC(=O)n1nc2c(c1NC(=O)c1ccc(N3CCN(C)CC3)cc1F)CNC2(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 2/20 0.40
KIT P10721 1/20 0.40
BTK Q06187 1/20 0.38
WDR5 P61964 1/20 0.38
NTRK1 P04629 5/20 0.36
NTRK3 Q16288 4/20 0.36
ALK Q9UM73 4/20 0.36
PLK4 O00444 1/20 0.36
DAPK3 O43293 1/20 0.36
PRKCG P05129 1/20 0.36
ROS1 P08922 1/20 0.36
FER P16591 1/20 0.36
LTK P29376 1/20 0.36
WEE1 P30291 1/20 0.36
FRK P42685 1/20 0.36
MAPK8 P45983 1/20 0.36
MST1R Q04912 1/20 0.36
PTK2 Q05397 1/20 0.36
TNK2 Q07912 1/20 0.36
DYRK1B Q9Y463 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4291464 0.99 FLT3 (0.40) FLT3KITBTKWDR5NTRK1
SCHEMBL1371503 0.87 SIRT6 (0.42) WDR5ALDH1A1MAPTSMN1; SMN2
Hydrochloric Acid SCHEMBL1371499 0.87 SIRT6 (0.42) WDR5ALDH1A1MAPTALOX12SMN1; SMN2
SCHEMBL1985468 0.86 MEN1 (0.48) FLT3NTRK1NTRK3NTRK2NPC1
SCHEMBL1206304 0.86 ALDH1A1 (0.40) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
Hydrochloric Acid SCHEMBL1985467 0.85 MEN1 (0.47) FLT3NTRK1NTRK3NTRK2NPC1
SCHEMBL4287277 0.84 WDR5 (0.37) FLT3KITBTKWDR5NTRK1
SCHEMBL1204639 0.82 ALDH1A1 (0.47) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL4279723 0.82 IGF1R (0.40) FLT3KITBTKWDR5NTRK1
SCHEMBL4278090 0.79 MAPT (0.41) NPC1ALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9012487-B2 Bicyclo-pyrazoles active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2015-04-21 US disclosed
US-9012487-B2 Bicyclo-pyrazoles active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2015-04-21 US disclosed
US-9012487-B2 Bicyclo-pyrazoles active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2015-04-21 US disclosed
EP-1999131-B1 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2013-10-23 EP disclosed
US-20090136513-A1 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L (IT) 2009-05-28 US disclosed
US-20090136513-A1 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L (IT) 2009-05-28 US disclosed
US-20090136513-A1 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L (IT) 2009-05-28 US disclosed
WO-2007099171-A2 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2007-09-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090136513-A1 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS MAP3K19, CDK2, MAP3K1 FLT3 218/4885KIT 323/4885BTK 300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.